Source link : https://www.newshealth.biz/health-news/slow-responders-to-zepbound-achieve-meaningful-weight-loss-eventually/
NEW ORLEANS — The vast majority of patients with obesity who responded slowly to the once-weekly injectable tirzepatide (Zepbound) achieved meaningful reductions in body weight a year later, a post hoc analysis of the SURMOUNT-1 trial showed. In study participants who failed to shed 5% of their body weight at 12 weeks, more than 90% […]
Author : News Health
Publish date : 2024-05-10 17:54:54
Copyright for syndicated content belongs to the linked Source.
Categories